CompletedNot Applicable

Complications of Midline Catheter in Surgical Children

South Korea48 participantsStarted 2025-04-21

Plain-language summary

The goal of this observational study is to understand the incidence and risk factors of complications associated with midline catheter placement in pediatric patients (under 18 years old) undergoing general anesthesia. The main questions it aims to answer are: What is the overall complication rate (including malfunction, bleeding, thrombosis, inflammation, and infection) after midline catheter placement in children? What factors (e.g., age, weight, vein diameter, insertion site, catheter maintenance duration) are associated with a higher risk of complications? Participants will: Receive a midline catheter during surgery under general anesthesia. Undergo ultrasound-guided assessment of the catheter site immediately after placement, 24 hours later, and before the catheter is removed. Be monitored for any complications related to the catheter, including infection, blood clots, or blockage. This study will help identify which factors increase the risk of complications, improving the safe use of midline catheters in pediatric patients.

Who can participate

Age range

1 Year – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pediatric patients under 18 years of age * Scheduled to undergo general anesthesia for surgery at Seoul National University Children's Hospital. * Clinically indicated for midline catheter insertion as determined by the attending anesthesiologist. Exclusion Criteria: * Patients requiring central venous catheter (CVC) insertion instead of a midline catheter. * Known coagulation disorders. * History of severe thrombosis. * Any other conditions that, in the investigator's judgment, make the patient unsuitable for the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of Participants with Complications Related to Midline Catheter

Timeframe: From midline catheter insertion to catheter removal (up to 7 days).

Trial details

NCT IDNCT06979167

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-23

View on ClinicalTrials.gov More Midline Catheter trials